company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q4,2010-08-01,2010-10-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,8577000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q4,2010-08-01,2010-10-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8577000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q4,2010-08-01,2010-10-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3341000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q4,2010-08-01,2010-10-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8933000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q4,2010-08-01,2010-10-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-10948000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q4,2010-08-01,2010-10-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,9903000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q4,2010-08-01,2010-10-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,9903000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q4,2010-08-01,2010-10-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4146000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q4,2010-08-01,2010-10-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4146000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q4,2010-08-01,2010-10-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4146000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q4,2010-08-01,2010-10-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1021000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q4,2010-08-01,2010-10-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-4306000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q4,2010-08-01,2010-10-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5327000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q4,2010-08-01,2010-10-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5327000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q4,2010-08-01,2010-10-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,430000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q4,2010-08-01,2010-10-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,450000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q4,2010-08-01,2010-10-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,7293000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7986000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7986000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3478000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,336000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6619000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5181000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5181000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6665000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-250000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6915000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6915000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-922000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1917000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,995000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,995000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-739000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,361000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1284000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7816000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7816000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3737000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4219000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-10757000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5015000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5015000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4813000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4813000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4813000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1004000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4931000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3927000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3927000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4129000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,402000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,12030000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,10081000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10081000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3835000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4212000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-16817000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1311000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1311000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-691000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-691000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-691000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1091000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1544000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2635000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2635000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2015000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,445000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,10371000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,10476000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10476000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3955000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-7047000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,12055000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,19439000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,19439000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1948000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1175000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3123000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3123000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1129000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-12328000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-13457000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-13457000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2859000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,546000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,9088000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7365000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7365000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3852000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1647000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1971000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10893000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10893000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7562000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7562000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7562000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1129000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2881000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1069000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-2941000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-2941000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,390000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,414000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,3758000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,9306000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9306000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4145000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2357000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3051000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,12757000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,12757000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2105000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-4375000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6480000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6480000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1168000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2312000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5474000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-8954000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-8954000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2677000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,347000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,16582000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,12596000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12596000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4272000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,809000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4766000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,12911000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,12911000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1692000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-400000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2092000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2092000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1311000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-8996000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-10307000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-10307000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,512000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,459000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,4524000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,12889000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12889000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4394000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-3663000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2917000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,16537000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,16537000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4356000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-900000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5256000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5256000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1372000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5004000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6376000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6376000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4905000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,327000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,11833000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,8665000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8665000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4447000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-907000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4591000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7614000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7614000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4821000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-7139000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11960000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11960000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1173000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,6692000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5519000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5519000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1173000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,255000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2874000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,11338000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11338000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4761000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1547000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12428000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,5218000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,5218000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5764000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,302000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5462000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5462000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1278000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2030000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2774000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-534000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-534000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-778000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,401000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,13465000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,14701000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,14701000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5001000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9344000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-24903000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,4143000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,4143000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7031000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-110000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7141000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7141000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1269000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7296000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6027000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6027000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3029000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,354000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,13048000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,11121000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11121000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5530000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-7836000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8128000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,687000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,687000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7484000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-12066000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-19550000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-19550000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1392000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,9640000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8248000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8248000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10615000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,493000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,14925000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,2954000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2954000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5689000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,358000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11753000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2752000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2752000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2771000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-258000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3029000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3029000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1600000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3962000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2362000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2362000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3419000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,583000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2813000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,10273000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10273000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6245000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,127000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-14081000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,2564000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,2564000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4277000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4277000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4277000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1576000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,13236000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,11660000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,11660000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9947000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,583000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,7054000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,15250000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15250000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6721000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-12991000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1287000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,7693000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,7693000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4018000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2072000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6090000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6090000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1729000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-4347000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6076000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6076000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4473000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,698000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,14087000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,18281000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18281000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6509000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13099000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-28819000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,9070000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,9070000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4457000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,27000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4430000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4430000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1789000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5351000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-7140000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-7140000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2500000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,555000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,12551000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,6633000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6633000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6533000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,25000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3134000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,10057000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,10057000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4149000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-29000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4178000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4178000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1744000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,598000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1146000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1146000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4733000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,570000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,2791000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,10461000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10461000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6698000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,76000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-16735000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,500000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,500000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-11590000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-225000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11815000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11815000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1738000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,15959000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,14221000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,14221000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2906000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,619000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,13747000.0
